TRVI vs. SSRM
TRVI (Trevi Therapeutics, Inc.) and SSRM (SSR Mining Inc.) are both stocks. TRVI operates in Biotechnology (Healthcare), while SSRM operates in Gold (Basic Materials). Over the past 5 years, TRVI returned 44.83%/yr vs 9.84%/yr for SSRM. At a 0.06 correlation, their price movements are largely independent.
Performance
TRVI vs. SSRM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TRVI achieves a 13.50% return, which is significantly lower than SSRM's 24.22% return.
TRVI
- 1D
- 5.57%
- 1M
- -6.94%
- YTD
- 13.50%
- 6M
- 11.28%
- 1Y
- 130.31%
- 3Y*
- 75.70%
- 5Y*
- 44.83%
- 10Y*
- —
SSRM
- 1D
- 3.46%
- 1M
- -21.64%
- YTD
- 24.22%
- 6M
- 22.60%
- 1Y
- 119.07%
- 3Y*
- 25.15%
- 5Y*
- 9.84%
- 10Y*
- 9.58%
TRVI vs. SSRM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
TRVI Trevi Therapeutics, Inc. | 13.50% | 203.88% | 207.46% | -30.57% | 146.74% | -67.68% | -35.47% | -60.53% |
SSRM SSR Mining Inc. | 24.22% | 214.94% | -35.32% | -29.94% | -10.02% | -10.90% | 4.41% | 72.43% |
Correlation
The correlation between TRVI and SSRM is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since May 7, 2019 | 0.06 |
The correlation between TRVI and SSRM shifts across timeframes, from 0.06 (all time) to 0.23 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
TRVI:
-$0.43
SSRM:
$3.27
TRVI:
$0.00
SSRM:
$1.90B
TRVI:
-$31.00K
SSRM:
$643.76M
TRVI:
-$49.16M
SSRM:
$835.27M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TRVI vs. SSRM — Risk / Return Rank
TRVI
SSRM
TRVI vs. SSRM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Trevi Therapeutics, Inc. (TRVI) and SSR Mining Inc. (SSRM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TRVI | SSRM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.37 | ||
| Sortino ratioReturn per unit of downside risk | +0.37 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.30 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | 4.44 | 3.83 | +0.62 |
| Martin ratioReturn relative to average drawdown | 10.40 | 9.89 | +0.51 |
Loading charts...
Drawdowns
TRVI vs. SSRM - Drawdown Comparison
The maximum TRVI drawdown since its inception was -95.45%, roughly equal to the maximum SSRM drawdown of -91.68%. Use the drawdown chart below to compare losses from any high point for TRVI and SSRM.
Loading charts...
Drawdown Indicators
| TRVI | SSRM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.45% | -91.68% | -3.77% |
Max Drawdown (1Y)Largest decline over 1 year | -29.50% | -31.28% | +1.78% |
Max Drawdown (3Y)Largest decline over 3 years | -61.96% | -73.41% | +11.45% |
Max Drawdown (5Y)Largest decline over 5 years | -80.26% | -83.16% | +2.90% |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.16% | — |
Current DrawdownCurrent decline from peak | -7.73% | -37.45% | +29.72% |
Average DrawdownAverage peak-to-trough decline | -61.49% | -57.15% | -4.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.58% | 12.09% | +0.49% |
Volatility
TRVI vs. SSRM - Volatility Comparison
The current volatility for Trevi Therapeutics, Inc. (TRVI) is 13.78%, while SSR Mining Inc. (SSRM) has a volatility of 19.31%. This indicates that TRVI experiences smaller price fluctuations and is considered to be less risky than SSRM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TRVI | SSRM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.78% | 19.31% | -5.53% |
Volatility (6M)Calculated over the trailing 6-month period | 39.38% | 54.27% | -14.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.39% | 66.63% | -6.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 88.26% | 55.93% | +32.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 99.35% | 52.96% | +46.39% |
Dividends
TRVI vs. SSRM - Dividend Comparison
Neither TRVI nor SSRM has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
SSRM SSR Mining Inc. | 0.00% | 0.00% | 0.00% | 2.60% | 1.79% | 1.13% |
TRVI Trevi Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TRVI vs. SSRM - Financials Comparison
This section allows you to compare key financial metrics between Trevi Therapeutics, Inc. and SSR Mining Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TRVI and SSRM have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SSRM has higher volatility (19.31%) compared to TRVI (13.78%). In terms of maximum drawdown, TRVI dropped -95.45% vs SSRM's -91.68%.
TRVI currently has the higher Sharpe Ratio (2.17 vs 1.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TRVI and SSRM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer